See If You Qualify For The RSV Research STudy
We are conducting a study for an investigational vaccine to see if it can protect older adults from the Respiratory Syncytial Virus (RSV). To qualify for this study you must be an adults aged 60 and older.
Qualified Participants will receive:
- Study-related RSV vaccine at no cost
- Study-related medical exams at no cost
- Compensation up to $1,800 for time and travel
How It Works
Subscribe To Our Newsletter
Subscribe to learn more about our clinical research trials, current and upcoming studies.